|
Market Closed -
Hong Kong S.E.
03:08:08 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 0.4250 HKD | -1.16% |
|
-2.30% | -15.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Chart: Technical Analysis
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2181 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 0.51 | 0.51 | 0.51 |
| Spread/Res. | -16.67% | -16.67% | -16.67% |
| Spread/Supp. | +14.86% | +14.86% | +11.84% |
| Support | 0.37 | 0.37 | 0.38 |
- Stock Market
- Stocks
- 2181 Stock
- Charts Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
